Page last updated: 2024-08-25

technetium tc 99m dimercaptosuccinic acid and Carcinoma in Situ

technetium tc 99m dimercaptosuccinic acid has been researched along with Carcinoma in Situ in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koutsikos, J; Lazaris, D; Louvrou, A; Mainta, E; Melissinou, M; Nakopoulou, L; Papantoniou, V; Pirmettis, I; Sotiropoulou, M; Souvatzoglou, M; Tsiouris, S; Tzannetaki, A; Valotassiou, V; Zerva, C1
Christodoulidou, J; Feda, H; Keramopoulos, A; Louvrou, A; Michalas, S; Pampouras, G; Papantoniou, V; Sotiropoulou, M; Stipsaneli, E; Zerva, C1

Trials

1 trial(s) available for technetium tc 99m dimercaptosuccinic acid and Carcinoma in Situ

ArticleYear
Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
    Breast cancer research : BCR, 2005, Volume: 7, Issue:1

    Topics: Aged; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Humans; Immunohistochemistry; Mammography; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi

2005

Other Studies

1 other study(ies) available for technetium tc 99m dimercaptosuccinic acid and Carcinoma in Situ

ArticleYear
Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of Tc-99m(V) DMSA.
    Clinical nuclear medicine, 2000, Volume: 25, Issue:6

    Topics: Breast; Breast Neoplasms; Calcinosis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Female; Humans; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi

2000